Dr. Woods is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
2160 S 1st Ave
Maywood, IL 60153Phone+1 708-216-9000
Education & Training
- Tulane UniversityResidency, Urology, 2002 - 2006
- Tulane UniversityInternship, Transitional Year, 2001 - 2002
- Loyola University Chicago Stritch School of MedicineClass of 2001
Certifications & Licensure
- IL State Medical License 2007 - 2026
- FL State Medical License 2020 - 2022
- NC State Medical License 2011 - 2022
- LA State Medical License 2003 - 2011
- American Board of Urology Urology
Clinical Trials
- Open Vs Robotic-Assisted Radical Cystectomy: A Randomized Trial Start of enrollment: 2011 Jul 01
- A Phase 1/2 Study of HS-410 in Patients With Non-Muscle Invasive Bladder Cancer After TURBT Start of enrollment: 2013 Dec 01
- Using Walk With Ease Walking Program With Men 65 and Older Being Treated for Prostate Cancer Start of enrollment: 2013 Oct 01
Publications & Presentations
PubMed
- Quantifying preserved renal volume and function in patients undergoing standard partial nephrectomy vs. tumor enucleation for localized renal tumors.Jeffrey L Ellis, Isaac Sontag-Milobsky, Victor S Chen, Goran Rac, Natalie C Hartman
Urologic Oncology. 2024-12-01 - MRI at diagnostic versus confirmatory biopsy during MRI-based active surveillance of prostate cancer.Madison Marras, Jeffrey L Ellis, Olivia Copelan, Ushasi Naha, Timothy Han
Urologic Oncology. 2024-10-01 - 9 citationsEfficacy of Intravesical Nadofaragene Firadenovec for Patients With Bacillus Calmette-Guérin-Unresponsive Nonmuscle-Invasive Bladder Cancer: 5-Year Follow-Up From a Ph...Vikram M Narayan, Stephen A Boorjian, Mehrdad Alemozaffar, Badrinath R Konety, Neal D Shore
The Journal of Urology. 2024-07-01
Press Mentions
- Advanced Bladder Cancers Respond to Immunotherapy Regardless of Gene Mutation StatusJuly 22nd, 2021
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: